InMed Pharmaceuticals (INM) Gross Profit Growth (1y) (2022 - 2025)
InMed Pharmaceuticals (INM) Gross Profit Growth (1y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 5.06% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 2.59% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | -7.66% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | -37.68% |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 42.12% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 14.77% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -163.22% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | -2.85% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -7.87% |
| 10 | InMed Pharmaceuticals | 5.94 Mn | 696,491.41 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -60.04% |
| Sep 30, 2025 | -18.29% |
| Jun 30, 2025 | 23.73% |
| Mar 31, 2025 | -39.33% |
| Dec 31, 2024 | 42.19% |
| Sep 30, 2024 | 2,222.82% |
| Jun 30, 2024 | -70.32% |
| Mar 31, 2024 | 50.36% |
| Dec 31, 2023 | 147.13% |
| Sep 30, 2023 | 104.33% |
| Jun 30, 2023 | 528.87% |
| Mar 31, 2023 | 5.61% |
| Dec 31, 2022 | 17.58% |